» Articles » PMID: 38644805

A Paper-based Dual Functional Biosensor for Safe and User-friendly Point-of-care Urine Analysis

Overview
Journal Lab Chip
Specialties Biotechnology
Chemistry
Date 2024 Apr 22
PMID 38644805
Authors
Affiliations
Soon will be listed here.
Abstract

Safe, accurate, and reliable analysis of urinary biomarkers is clinically important for early detection and monitoring of the progression of chronic kidney disease (CKD), as it has become one of the world's most prevalent non-communicable diseases. However, current technologies for measuring urinary biomarkers are either time-consuming and limited to well-equipped hospitals or lack the necessary sensitivity for quantitative analysis and post a health risk to frontline practitioners. Here we report a robust paper-based dual functional biosensor, which is integrated with the clinical urine sampling vial, for the simultaneous and quantitative analysis of pH and glucose in urine. The pH sensor was fabricated by electrochemically depositing IrOx onto a paper substrate using optimised parameters, which enabled an ultrahigh sensitivity of 71.58 mV pH. Glucose oxidase (GOx) was used in combination with an electrochemically deposited Prussian blue layer for the detection of glucose, and its performance was enhanced by gold nanoparticles (AuNPs), chitosan, and graphite composites, achieving a sensitivity of 1.5 μA mM. This dual function biosensor was validated using clinical urine samples, where a correlation coefficient of 0.96 for pH and 0.98 for glucose detection was achieved with commercial methods as references. More importantly, the urine sampling vial was kept sealed throughout the sample-to-result process, which minimised the health risk to frontline practitioners and simplified the diagnostic procedures. This diagnostic platform, therefore, holds high promise as a rapid, accurate, safe, and user-friendly point-of-care (POC) technology for the analysis of urinary biomarkers in frontline clinical settings.

Citing Articles

Understanding the Electrochemical MOF Sensors in Detecting Cancer with Special Emphasis on Breast Carcinoma Biomarkers.

Mohan B, Modi K, Singh G, Paul A, Garazade I, Pombeiro A Top Curr Chem (Cham). 2025; 383(1):9.

PMID: 39966301 DOI: 10.1007/s41061-025-00493-0.

References
1.
Lee H, Hong Y, Baik S, Hyeon T, Kim D . Enzyme-Based Glucose Sensor: From Invasive to Wearable Device. Adv Healthc Mater. 2018; 7(8):e1701150. DOI: 10.1002/adhm.201701150. View

2.
Lei Y, Zhao W, Zhang Y, Jiang Q, He J, Baeumner A . A MXene-Based Wearable Biosensor System for High-Performance In Vitro Perspiration Analysis. Small. 2019; 15(19):e1901190. DOI: 10.1002/smll.201901190. View

3.
Lipani L, Dupont B, Doungmene F, Marken F, Tyrrell R, Guy R . Non-invasive, transdermal, path-selective and specific glucose monitoring via a graphene-based platform. Nat Nanotechnol. 2018; 13(6):504-511. DOI: 10.1038/s41565-018-0112-4. View

4.
Li Y, Luo L, Nie M, Davenport A, Li Y, Li B . A graphene nanoplatelet-polydopamine molecularly imprinted biosensor for Ultratrace creatinine detection. Biosens Bioelectron. 2022; 216:114638. DOI: 10.1016/j.bios.2022.114638. View

5.
Hill N, Fatoba S, Oke J, Hirst J, OCallaghan C, Lasserson D . Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(7):e0158765. PMC: 4934905. DOI: 10.1371/journal.pone.0158765. View